Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed at demonstrating whether or not Male Circumcision can be used as an effective public health prevention tool that will have an impact on HIV prevalence in the South African population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

NCT00122525

HIV Infections Herpes Genitalis Venereal Diseases

TERMINATED PHASE3

Papuan Indigenous Model of Male Circumcision

NCT06212531

HIV Infections

COMPLETED NA

Male Circumcision for HIV Prevention in Rakai, Uganda

NCT00425984

HIV Infections Herpesvirus 2, Human Syphilis +1 more

COMPLETED PHASE3

Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa

NCT02038582

HIV

COMPLETED NA

Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya

NCT02497989

HIV/AIDS

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized, controlled trial (ANRS 1265) conducted in Orange Farm (South Africa) has demonstrated that male circumcision (MC) can reduce the risk of HIV acquisition by more than 50% among young men. This result has been confirmed by two similar studies conducted in Uganda and in Kenya.

Giving these findings, the next logical step is to demonstrate whether or not MC can be used as an effective public health prevention tool that will have an impact on HIV in populations as well as among individuals.

This research study aims to establish a MC intervention in the community where the first randomized controlled trial of the impact of MC on men's risk of acquiring HIV infection was carried out in order to evaluate its impact on:

1. knowledge, attitudes and practice regarding MC
2. existing means of prevention (sexual behavior change, condom use, STI treatment-seeking behavior and VCT (voluntary counseling and testing) attendance)
3. the spread of HIV and HSV-2

This research will be carried out over a period of 60 months and will have three major components: (1) the delivery of the intervention, (2) quantitative studies (cross-sectional surveys), and (3) qualitative studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Male circumcision by experimented doctor or nurse

Group Type EXPERIMENTAL

Male Circumcision

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Male Circumcision

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* being uncircumcised
* living in Orange Farm (South Africa) for more than 3 months
* agreeing to follow the instructions given by doctors, nurses and/or staff, and in particular to abstain from sex for 6-weeks after being circumcised
* having understood and sign a consent form written in their own language
* for those younger than 18 years of age having a written authorization from one parent or guardian and having signed an assent form.

Exclusion Criteria

* subjects with contraindications for male circumcision
* allergy to anesthesia
* hemophilia or bleeding disorders
* genital ulceration or other symptoms of sexually transmitted infections
* signs of infections or AIDS
* abnormal genital anatomy
* history of diabetes

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes